background
vaccin
passiv
antibodi
therapi
critic
control
infecti
diseas
passiv
antibodi
administr
limit
includ
necess
purif
multipl
inject
efficaci
vaccin
associ
lag
phase
gener
immun
novel
approach
report
util
benefit
method
rapid
gener
effect
immun
method
novel
antibodybas
prophylaxistherapi
entail
electroporationmedi
deliveri
synthet
dna
plasmid
encod
biolog
activ
antichikungunya
viru
chikv
envelop
monoclon
antibodi
dmab
design
evalu
antivir
efficaci
well
abil
overcom
shortcom
inher
convent
activ
vaccin
passiv
immunotherapi
result
one
intramuscular
inject
dmab
produc
antibodi
vivo
rapidli
activ
vaccin
antichikv
dna
vaccin
dmab
neutral
divers
chikv
clinic
isol
protect
mice
viral
challeng
combin
dmab
chikv
dna
vaccin
afford
rapid
longliv
protect
conclus
dnabas
dmab
strategi
induc
rapid
protect
emerg
viral
infect
method
combin
dna
vaccin
novel
strategi
provid
shortand
longterm
protect
emerg
infecti
diseas
studi
implic
pathogen
treatment
control
strategi
activ
vaccin
passiv
immunotherapi
rank
among
greatest
medic
achiev
howev
improv
immunebas
medic
intervent
requir
articl
describ
novel
strategi
develop
shortand
longterm
protect
immun
chikungunya
viru
chikv
infect
use
relev
emerg
infecti
diseas
model
chikv
mosquitoborn
rna
pathogen
infect
million
precipit
increas
case
chikv
infect
diseas
recent
report
along
increas
morbid
mortal
suggest
increas
virul
find
underscor
import
develop
antichikv
prophylaxi
therapi
date
howev
chikv
vaccin
licens
although
varieti
strategi
evalu
importantli
antichikv
neutral
antibodi
titer
may
protect
immun
correl
passiv
immunotherapi
import
shortterm
intervent
sever
infecti
diseas
includ
monoclon
antibodi
mab
prophylaxi
respiratori
syncyti
viru
howev
passiv
antibodi
deliveri
limit
short
halflif
immunoglobulin
convent
vaccin
typic
requir
lag
phase
antibodi
gener
addit
multipl
immun
effect
furthermor
vaccinationinduc
protect
problemat
popul
ie
immunocompromis
individu
limit
immun
control
infect
outbreak
group
rapid
local
spread
chikv
underscor
import
confer
effect
time
immun
protect
passiv
antibodi
therapi
strategi
attract
method
shortterm
intervent
virus
chikv
cost
product
complex
cold
chain
requir
limit
approach
therefor
develop
novel
immunotherapeuticprophylact
modal
overcom
limit
warrant
one
strategi
vivo
deliveri
express
plasmid
encod
gene
immunoglobulin
chain
establish
function
mab
approach
bypass
convent
antibodi
product
may
present
uniqu
opportun
therapi
includ
combin
vaccin
group
recent
describ
vivodeliveri
method
involv
electropor
dna
plasmid
encod
mab
design
dmab
rather
viral
vector
compar
viral
vectormedi
platform
ie
adenoassoci
viral
vector
mab
deliveri
nake
dna
plasmid
repres
nonliv
nonintegr
noninfecti
platform
gener
antivector
immun
accordingli
may
advantag
rapid
antibodi
product
readministr
lack
serolog
interfer
often
encount
convent
immunebas
strategi
studi
demonstr
vivo
product
deliveri
chikv
dmab
deriv
establish
antichikv
envelop
env
human
neutral
mab
result
seroconvers
could
protect
lethal
vivo
viral
challeng
effect
dmab
deliveri
coadminist
chikv
env
antigenbas
dna
vaccin
also
evalu
combin
approach
result
shortand
longterm
protect
lethal
chikv
challeng
strategi
may
implic
chikv
infecti
diseas
gene
sequenc
inform
establish
antienvspecif
chikv
neutral
human
mab
obtain
nation
center
biotechnolog
inform
databas
human
embryon
kidney
cell
vero
cell
use
express
confirm
studi
maintain
describ
previous
variabl
heavi
vh
variabl
light
vl
chain
segment
chikv
env
dmab
prepar
gener
use
synthet
oligonucleotid
sever
modif
construct
either
fulllength
immunoglobulin
g
igg
design
fab
fragment
design
clone
singl
open
read
frame
assembl
contain
heavi
light
chain
gene
separ
furin
cleavag
site
coupl
selfprocess
peptid
sequenc
transgen
clone
express
vector
vh
vl
chain
clone
separ
vector
tissu
cultur
transfect
dna
vh
vl
construct
use
chikv
envbas
dna
vaccin
use
studi
develop
character
previous
describ
enzymelink
immunosorb
assay
elisa
perform
sera
collect
measur
duplic
mice
administ
quantifi
express
kinet
target
antigen
bind
measur
analys
perform
previous
describ
western
blot
analysi
igg
express
chikv
viral
isol
infect
cell
lyse
two
day
post
infect
evalu
previous
publish
method
immunofluoresc
analysi
chamber
slide
nalgen
nunc
penfield
new
york
seed
vero
cell
infect
hour
viral
isol
chikv
multipl
infect
immunofluoresc
analysi
perform
previous
describ
slide
visual
evalu
confoc
microscopi
carl
zeiss
result
imag
semiquantit
analyz
use
zen
softwar
carl
zeiss
dmab
dna
plasmid
administr
vivo
analysi
express
kinet
function
evalu
mice
jackson
laboratori
follow
intramuscular
inject
control
plasmid
chain
studi
includ
dna
vaccin
chikv
env
plasmid
inject
time
interv
inject
follow
immedi
deliveri
chikv
dmab
dna
plasmid
via
electropor
anim
studi
approv
committe
anim
care
univers
pennsylvania
balbc
mice
receiv
singl
electroporationenhanc
intramuscular
inject
cmvfab
vh
vl
control
plasmid
chikv
env
dna
vaccin
deliv
describ
two
day
dna
deliveri
mice
challeng
plaqueform
unit
viral
isol
chikv
either
subcutan
dorsal
side
hind
foot
intranas
mous
foot
swell
height
breadth
measur
daili
day
infect
addit
anim
monitor
daili
day
infect
surviv
sign
infect
ie
chang
bodi
weight
lethargi
anim
lose
bodi
mass
euthan
serum
sampl
collect
cytokin
quantif
immun
analysi
blood
sampl
collect
tail
day
infect
viremia
level
measur
plaqu
assay
antichikv
neutral
antibodi
titer
mice
administ
determin
previous
describ
method
use
vero
cell
infect
follow
chikv
isol
indian
ocean
outbreak
asianclad
ross
ecsaclad
ecsaclad
neutral
titer
calcul
reciproc
highest
dilut
mediat
reduct
cytopath
effect
vero
cell
monolay
data
gener
statist
analys
perform
use
graphpad
prism
softwar
packag
graphpad
softwar
nonlinear
regress
fit
sigmoid
dose
respons
use
determin
level
antibodi
mediat
inhibit
infect
ic
chikv
env
pseudotyp
product
fluorescenceactiv
cellsort
fac
analysi
perform
describ
previous
sera
collect
mice
inject
chikv
env
well
challeng
chikv
week
challeng
tumor
necrosi
factor
interleukin
interleukin
level
sera
measur
use
elisa
kit
accord
manufactur
instruct
r
system
student
test
nonparametr
spearman
correl
test
perform
use
graphpad
prism
softwar
prism
la
jolla
california
correl
variabl
control
experiment
group
statist
evalu
use
spearman
rank
correl
test
p
valu
consid
statist
signific
test
viral
entri
host
cell
chikv
mediat
env
major
neutral
antibodi
gener
thu
dna
plasmid
dmab
express
light
heavi
immunoglobulin
chain
neutral
antichikv
mab
recogn
env
protein
design
complementari
dna
code
sequenc
vl
vh
immunoglobulin
chain
fulllength
antichikv
dmab
optim
increas
express
clone
vector
use
previous
describ
method
construct
express
antichikvfab
vh
vl
gene
clone
separ
optim
synthet
plasmid
construct
antienvspecif
chikvneutr
mab
design
igg
fab
antibodi
respect
human
cell
transfect
either
plasmid
vl
vh
combin
plasmid
valid
express
vitro
indic
figur
antichikv
antibodi
figur
g
igg
dmab
plasmid
design
express
b
vitro
express
heavi
chain
vh
light
chain
vl
construct
transfect
cell
determin
vitro
express
bind
enzymelink
immunosorb
assay
elisa
sampl
analyz
hour
posttransfect
cell
transfect
empti
backbon
plasmid
serv
neg
control
c
vivo
express
mice
age
week
receiv
singl
intramuscular
inject
plasmid
follow
electropor
mice
per
group
inject
vector
use
neg
control
sera
igg
level
measur
variou
time
point
mice
inject
intramuscularli
describ
materi
method
section
sera
mice
bind
chikungunya
viru
chikv
envelop
protein
env
elisa
plate
coat
recombin
chikv
envelop
human
immunodefici
viru
type
subtyp
b
mn
envelop
protein
sera
obtain
day
mice
given
singl
inject
test
b
mean
od
valu
shown
level
measur
elisa
recombin
chikv
env
use
bind
antigen
data
indic
express
antibodi
muscl
appear
properli
assembl
biolog
function
vitro
follow
confirm
vitro
express
abil
produc
antichikv
antibodi
vivo
measur
nu
j
mice
age
week
administ
plasmid
vh
vl
consist
plasmid
control
vector
singl
intramuscular
electroporationmedi
inject
sera
collect
indic
time
point
target
antigen
bind
measur
igg
quantif
use
elisa
although
mab
gener
appear
rapidli
ie
within
day
inject
construct
gener
similar
mab
level
day
mean
sera
level
ngml
ng
ml
figur
mice
administ
either
sera
antibodi
level
evalu
bind
elisa
sera
collect
day
inject
bound
chikv
env
protein
unrel
control
antigen
human
immunodefici
viru
type
env
figur
data
indic
vivo
produc
antichikv
antibodi
construct
similar
biolog
characterist
convent
produc
antigen
specif
antibodi
antichikv
dmab
gener
mab
test
bind
specif
antichikv
neutral
activ
sera
mice
inject
test
fix
chikv
vero
cell
immunofluoresc
assay
result
indic
bind
sera
antibodi
chikvinfect
cell
figur
confirm
bind
sera
mice
target
protein
test
western
blot
analysi
detect
chikv
protein
kda
express
total
cell
lysat
chikvinfect
cell
indic
specif
express
figur
specif
vivoproduc
antibodi
demonstr
fac
analysi
cell
infect
green
fluoresc
proteinencod
chikv
figur
moreov
bind
demonstr
immunohistochem
analysi
fac
analysi
similar
gener
fulllength
data
shown
togeth
find
indic
strong
specif
antibodi
gener
plasmid
furthermor
antichikv
neutral
activ
sera
mice
receiv
measur
diverg
chikv
strain
indian
ocean
outbreak
asianclad
ross
ecsaclad
ecsaclad
asianclad
ecsaclad
ic
valu
determin
viral
isol
sera
mice
effect
neutral
chikv
isol
demonstr
singl
inject
produc
signific
neutral
level
human
antichikv
igg
mice
figur
similar
result
observ
use
sera
mice
data
shown
data
indic
antibodi
produc
vivo
construct
relev
biolog
activ
ie
bind
neutral
activ
chikv
previou
studi
demonstr
earli
immun
virus
key
factor
control
infect
determin
whether
antibodi
gener
provid
protect
earli
exposur
chikv
group
mice
receiv
singl
administr
day
group
subsequ
challeng
subcutan
viru
day
mimic
natur
chikv
infect
figur
anim
surviv
weight
chang
subsequ
record
day
mice
inject
control
plasmid
die
within
week
viral
challeng
convers
surviv
observ
mice
administ
either
compar
surviv
among
mice
receiv
plasmid
p
demonstr
plasmid
confer
protect
immun
within
day
deliveri
longev
immun
protect
next
evalu
second
group
mice
n
challeng
chikv
day
singl
inject
day
figur
mice
monitor
surviv
next
day
mice
inject
demonstr
surviv
respect
compar
surviv
among
mice
p
indic
provid
durabl
degre
immun
protect
figur
assess
abil
plasmid
protect
infect
mucos
surfac
protect
efficaci
subcutan
versu
intranas
viral
challeng
previous
demonstr
produc
visibl
chikv
pathogenesi
limb
muscl
weak
footpad
swell
lethargi
high
mortal
within
day
infect
evalu
simplic
studi
focus
construct
group
mice
receiv
singl
administr
half
ie
challeng
chikv
via
subcutan
intranas
rout
day
inject
protect
mice
subcutan
viral
challeng
p
figur
intranas
viral
challeng
p
figur
compar
mice
demonstr
protect
system
mucos
infect
studi
compar
protect
efficaci
administr
vs
chikv
envexpress
dna
vaccin
chikv
env
next
perform
novel
consensusbas
dna
vaccin
develop
laboratori
capabl
provid
protect
chikv
challeng
mice
dna
vaccin
also
induc
measur
cellular
immun
respons
well
potent
neutral
antibodi
respons
rhesu
macaqu
group
mice
administ
singl
inject
chikv
env
follow
viral
challeng
day
inject
mice
receiv
singl
immun
chikv
env
die
within
day
viral
challeng
wherea
singl
immun
provid
protect
figur
clearli
confer
protect
immun
rapidli
chikv
env
dna
vaccin
p
next
longterm
chikv
challeng
protect
studi
perform
day
follow
vaccin
chikv
env
dna
vaccin
administr
day
multiboost
deliveri
chikv
env
dna
vaccin
confer
protect
figur
surviv
observ
mice
administ
p
kinet
induc
antibodi
respons
measur
within
day
singl
inject
peak
level
day
approxim
ngml
detect
mab
level
maintain
least
day
inject
supplementari
figur
although
continu
express
level
decreas
compar
peak
level
support
partial
protect
note
experi
figur
immunofluoresc
assay
demonstr
igg
gener
mice
capabl
bind
chikungunya
viru
chikv
envelop
protein
env
chikvinfect
vero
cell
fix
hour
infect
evalu
immunofluoresc
assay
detect
chikv
env
antigen
express
green
cell
nuclei
stain
dapi
blue
sera
control
mice
inject
use
neg
control
b
bind
affin
sera
mice
day
target
protein
test
western
blot
use
cell
lysat
chikvor
mockinfect
cell
describ
materi
method
section
protein
transfer
membran
reprob
antibodi
use
load
control
imag
present
crop
origin
imag
repres
sever
gel
c
fluorescenceactiv
cellsort
analysi
bind
sera
plasmidinject
mice
chikvinfect
cell
xaxi
indic
green
fluoresc
protein
gfp
stain
use
lentivir
gfp
pseudoviru
complement
chikv
env
yaxi
demonstr
stain
infect
cell
human
igg
produc
mice
day
inject
stain
control
antichikv
antibodi
env
antibodi
also
shown
well
stain
antibodi
presenc
number
doubleposit
cell
indic
presenc
level
sera
bind
chikvinfect
cell
sera
mice
inject
via
electropor
possess
neutral
activ
multipl
chikv
strain
ie
ross
neutral
antibodi
titer
plot
inhibitori
concentr
ic
valu
parenthesi
calcul
prism
graphpad
softwar
similar
result
observ
independ
experi
least
mice
per
group
experi
one
potenti
issu
combin
antibodi
deliveri
vaccin
approach
antibodi
neutral
mani
tradit
vaccin
thu
incompat
platform
effect
coadminstr
chikv
env
mous
surviv
context
chikv
challeng
also
evalu
experi
mice
administ
day
singl
dose
dose
chikv
env
dna
describ
subsequ
half
anim
challeng
chikv
day
half
day
surviv
group
follow
function
time
unexpectedli
challeng
group
longterm
surviv
figur
specif
result
day
chikv
challeng
experi
indic
util
reagent
mediat
protect
infect
surviv
percentag
decreas
approxim
day
challeng
control
anim
figur
indic
level
antichikv
igg
time
gener
mice
receiv
chikv
env
dna
vaccin
antichikv
human
igg
repres
antibodi
produc
plasmid
antichikv
mous
igg
repres
antibodi
induc
chikv
env
vaccin
human
igg
mous
igg
detect
exhibit
differ
express
kinet
day
initi
chikv
env
dna
vaccin
mous
antienv
antibodi
level
essenti
near
mous
antichikv
igg
convers
day
singl
inject
human
antienv
antibodi
level
signific
human
antichikv
igg
data
underscor
import
mediat
rapid
protect
infect
death
chikv
challeng
furthermor
tcell
respons
induc
anim
inject
chikv
env
plu
chikv
env
evalu
quantit
enzymelink
immunospot
assay
measur
level
supplementari
figur
chikv
env
elicit
strong
tcell
respons
irrespect
codeliveri
show
lack
interfer
approach
convers
anim
administ
develop
tcell
respons
would
expect
find
demonstr
chikv
env
dna
vaccin
administ
simultan
without
reciproc
interfer
provid
immedi
longliv
protect
via
system
humor
cellular
immun
previou
studi
identifi
molecular
correl
chikvassoci
diseas
sever
includ
viral
load
proinflammatori
cytokin
level
thu
abil
igg
suppress
diseaseassoci
marker
earli
late
time
point
viral
challeng
assess
mice
immun
igg
fab
chikv
env
igg
plu
chikv
env
dna
vaccin
gener
mab
significantli
reduc
viral
load
figur
addit
viral
load
reduct
mice
exhibit
footpad
swell
compar
control
immun
mice
consist
gain
bodi
weight
experiment
period
figur
also
mab
chikv
env
dna
vaccin
exhibit
significantli
reduc
level
chikvmedi
proinflammatori
cytokin
ie
compar
day
viral
challeng
supplementari
figur
find
suggest
singl
inject
suppress
chikvassoci
patholog
extent
compar
induc
protect
vaccin
half
mice
challeng
day
remain
half
challeng
day
condit
chikv
isol
challeng
describ
black
arrow
indic
plasmid
inject
red
arrow
indic
time
viral
challeng
studi
mice
monitor
day
challeng
surviv
rate
record
induct
persist
system
antichikv
env
antibodi
follow
singl
human
antichikv
env
inject
chikvenv
immun
mous
antichikv
env
week
second
immun
mice
bind
enzymelink
immunosorb
assay
perform
describ
materi
method
section
mean
od
valu
shown
antigenbas
vaccin
requir
lag
period
vaccin
recipi
remain
suscept
infect
diseas
use
passiv
antibodi
therapi
advantag
sever
highrisk
popul
either
respond
poorli
activ
vaccin
manifest
signific
vaccinerel
side
effect
would
major
advantag
gener
effect
specif
vivo
immun
rapidli
without
need
repeat
administr
preform
antibodi
signific
lag
time
immun
respons
gener
follow
convent
antigenbas
immun
studi
novel
synthet
dnadeliveri
system
dmab
gener
rapid
immun
protect
evalu
use
emerg
chikv
model
increas
incid
geograph
spread
chikv
infect
emerg
viral
infect
rais
concern
potenti
global
outbreak
underscor
need
target
antivir
intervent
current
neither
vaccin
therapi
chikv
infect
licens
evid
suggest
humor
immun
play
critic
role
protect
chikv
infect
group
previous
demonstr
passiv
transfer
sera
mice
immun
chikv
env
dna
vaccin
protect
naiv
mice
lethal
chikv
challeng
highlight
util
antibodybas
therapi
well
prompt
interest
develop
novel
approach
provid
sourc
antichikv
antibodi
gener
directli
vivo
studi
demonstr
util
electroporationmedi
deliveri
optim
dna
plasmid
vivo
rapid
product
biolog
function
mab
unlik
viral
vector
dna
plasmid
pose
risk
genom
integr
gener
antivector
immun
allow
booster
immun
covaccin
multipl
dna
plasmid
figur
character
patholog
footpad
swell
chang
weight
viralchalleng
mice
vaccin
g
igg
andor
chikungunya
viru
chikv
envelop
protein
env
dna
viral
titer
week
chikv
challeng
mice
receiv
chikvenv
plu
chikvenv
control
data
point
repres
averag
viral
titer
mice
error
bar
indic
standard
error
mean
b
mean
daili
weight
gain
deviat
sd
subcutan
inocul
chikv
isol
among
mice
receiv
chikvenv
plu
chikvenv
mice
weigh
specifi
day
inocul
result
present
mean
bodi
weight
c
swell
hind
feet
quantifi
use
calip
specifi
day
among
mice
receiv
chikvenv
plu
chikvenv
data
mean
valu
abbrevi
pfu
plaqueform
unit
addit
stabl
facilit
manufactur
stockpil
obviat
necess
refriger
cold
chain
strategi
could
also
particularli
use
combat
pathogen
adept
escap
immun
respons
sinc
multipl
plasmid
encod
antibodi
target
differ
epitop
could
administ
without
serolog
interfer
studi
demonstr
mice
inject
singl
dose
igg
fulli
protect
viral
challeng
day
administr
wherea
mice
surviv
infect
follow
singl
immun
chikv
env
dna
vaccin
owe
presum
insuffici
time
mount
protect
immun
howev
complet
protect
observ
chikv
env
immun
regimen
follow
challeng
later
time
point
similar
level
protect
occur
mice
administ
singl
dose
although
protect
wane
time
notabl
codeliveri
chikv
env
produc
rapid
persist
humor
cellular
immun
suggest
combin
approach
addit
synergist
effect
importantli
codeliveri
chikv
env
antagonist
term
develop
shortor
longterm
protect
immun
respons
provid
new
import
approach
provid
infect
resist
relev
pathogen
studi
like
import
varieti
infecti
noninfecti
diseas
supplementari
materi
avail
http
jidoxfordjournalsorg
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
author
